Yibei Li, Danqi Huang, Jingyi Liu, et al. J Natl Cancer Cent. 2026 Feb 11;6(2):149-158
Early-onset cancer is a significant public health threat in females, yet comprehensive data on its global burden and temporal trends remain limited. This study analyzed the incidence, mortality, and disability-adjusted life years...
Read More
Silvia Mignozzi, Claudia Santucci, Gianfranco Alicandro, et al. Cancer Causes Control. 2026 Apr 3;37(5):79
An increasing cancer incidence has been observed among recent generations over the last decade. However, apart from colorectal cancer, these increases were not associated with rises in mortality. We extracted death counts for indi...
Read More
Rami James N Aoun and Matthew F Kalady. Surg Oncol. 2022 Aug: 43:101765
Approximately 5% of colorectal cancers arise within an inherited colorectal cancer syndrome, with known underlying genetic etiologies. These syndromes increase the risk of colorectal and extracolonic cancers. Identification of a s...
Read More
Abdosaleh Jafari, Fatemeh A Hosseini, Faride S Jalali et al.Health Sci Rep. 2024 Aug 21;7(8):e70002
Colorectal cancer is the third most common cancer in the Western Hemisphere. It is the third most common cancer in men after prostate and lung cancers and the second most common cancer in women after breast cancer. The data from 3...
Read More
Ke Lu and Gang Xu. Front Oncol 2026 Feb 27:16:1690349
Colorectal cancer (CRC), the third most common malignant cancer globally, imposes a substantial public health burden. Emerging evidence has highlighted hyperglycemia as an independent risk factor for CRC. Globally, high fasting pl...
Read More
Michael Bretthauer, Magnus Løberg, Paulina Wieszczy, et al. N Engl J Med. 2022;387:1547-1556
We performed a pragmatic, randomized trial involving presumptively healthy men and women 55 to 64 years of age drawn from population registries in Poland, Norway, Sweden, and the Netherlands between 2009 and 2014. The participants...
Read More
S. Ogino and T. Ugai. Annals of Oncol;.35(12) 1071-1073. 2024
The incidence of early-onset cancer (EOC) diagnosed in individuals under the age of 50 has been increasing worldwide, which may be just the tip of the iceberg of larger emerging issues, including the rise of various chronic diseas...
Read More
Chi M Nguyen, Paul G Yeh, Mai P Nguyen, et al. Cancer Res Commun. 2025 Oct 1;5(10):1852-1864
Colorectal cancer is a leading cause of cancer-related death and among the costliest cancers to treat in the United States. This study highlights the substantial economic burden of mCRC, with medical and prescription costs nearly...
Read More
Cancer imposes a substantial economic burden on patients that may be worse in patients with higher-stage disease due to the need for more therapy. The cohort consisted of 46,158 patients (mean age at diagnosis, 46 years; 30,...
Read More
Ziting Wu , Yiwen Yu, Feng Xie, et al. BMC Health Serv Res. 2024 Sep 27;24(1): 1135
China accounts for 24% of newly diagnosed cancer cases and 30% of cancer-related deaths worldwide. This study aims to estimate the financial burden borne by patients and analyze the cost compositions of the leading cancers with th...
Read More
Aug.Abdosaleh Jafari, Fatemeh A Hosseini, Faride S Jalali et al. Health Sci Rep. 2024 Aug 21;7(8):e70002
Colorectal cancer is the third most common cancer in the Western Hemisphere. It is the third most common cancer in men after prostate and lung cancers and the second most common cancer in women after breast cancer. According to so...
Read More
Cancer imposes a substantial economic burden on patients that may be worse in patients with higher-stage disease due to the need for more therapy. This retrospective cohort study used administrative claims data of a large national...
Read More